NewLink Genetics Corp. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
37.21 M |
Public Float |
28.83 M |
NewLink Genetics Corp. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.22 |
Market Cap |
$54.42 M |
Shares Outstanding |
37.28 M |
Public Float |
28.76 M |
Address |
2503 South Loop Drive Ames Iowa 50010 United States |
Employees | - |
Website | http://www.newlinkgenetics.com |
Updated | 07/08/2019 |
NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. |